COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says

(Reuters) – The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year.

(Reporting by Leroy Leo in Bengaluru; Editing by Tasim Zahid)